The chemical class of CCSER1 Inhibitors encompasses a range of compounds conceptualized to modulate the activity of CCSER1, a protein characterized by its coiled-coil domains and serine-rich regions. This class is characterized not by a uniform chemical structure but rather by a shared functional objective: to influence CCSER1's role in protein-protein interactions and in signaling pathways. These inhibitors operate through various mechanisms, each targeting different facets of CCSER1's activity or its interaction within the cellular environment. The primary aim of these compounds is to alter the functional processes involving CCSER1, either by directly affecting its interaction with other proteins or by modifying the conditions essential for its function.
One of the primary methods of inhibition focuses on compounds that target the protein-protein interaction capabilities of CCSER1. By disrupting these interactions, which are crucial for CCSER1's presumed functions in cellular organization and signaling, these inhibitors aim to influence the role CCSER1 plays within the cell. This method of inhibition is based on the understanding that CCSER1's primary function is likely related to its structural role in forming complexes with other proteins. Another significant approach involves targeting the upstream signaling pathways that may regulate the activity of CCSER1. Since the regulation of protein-protein interactions and cellular signaling is often controlled by a complex network of signaling pathways, modulating these pathways can impact CCSER1's function. This indirect method of inhibition recognizes the intricate web of cellular signals that govern protein interaction dynamics and aims to modify CCSER1's activity by altering its regulatory environment. The exploration of CCSER1 Inhibitors is crucial in the field of molecular biology, focusing on the modulation of key proteins involved in cellular organization and signaling. By concentrating on a protein with unique structural features, this class of inhibitors offers insights into the sophisticated interplay between structural proteins and the signaling mechanisms that control them. The development of these inhibitors contributes to a deeper understanding of the mechanisms underlying protein-protein interactions and cellular signaling. Furthermore, it highlights the complexity of targeting specific protein functions within the elaborate framework of cellular systems. The study of CCSER1 inhibitors is instrumental in advancing our knowledge of cellular dynamics and has the potential to provide foundational insights into the regulation of protein interactions and cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A could possibly inhibit FAM190A by disrupting its coiled-coil mediated protein-protein interactions, crucial for its function. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $50.00 $120.00 $420.00 $834.00 $1836.00 $4896.00 | 33 | |
AEBSF hydrochloride, a serine protease inhibitor, might affect FAM190A by altering serine-dependent processes or modifications. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine, a kinase inhibitor, could possibly inhibit FAM190A by modulating phosphorylation pathways in which FAM190A might be involved. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A, as a phosphatase inhibitor, could impact signaling pathways related to FAM190A's function, possibly inhibiting its activity. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine, affecting cytoskeletal dynamics, could possibly influence FAM190A's interactions with cytoskeletal components. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
NSC23766, a GTPase inhibitor, might impact intracellular signaling processes, potentially inhibiting pathways involving FAM190A. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132, a proteasome inhibitor, could possibly influence the stability and levels of FAM190A. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide, inhibiting protein synthesis, could possibly influence the production and functionality of FAM190A. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid could possibly impact the transcription or translation of FAM190A, influencing its expression levels and function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin, disrupting protein synthesis, might affect FAM190A's levels and functionality. | ||||||